Modeling of serpin-protease complexes: antithrombin-thrombin, alpha 1-antitrypsin (358Met-->Arg)-thrombin, alpha 1-antitrypsin (358Met-->Arg)-trypsin, and antitrypsin-elastase

Proteins
J WhisstockR W Carrell

Abstract

Based on the most recent available crystal structures and biochemical studies of protease complexes of normal and mutant serine protease inhibitors (serpins), we have built models of the complexes: alpha 1-antitrypsin + human neutrophil elastase; alpha 1-antitrypsin Pittsburgh (358Met-->Arg) (Scott et al., J. Clin. Invest. 77:631-634, 1986) + tyrpsin; alpha 1-antitrypsin Pittsburgh (358Met-->Arg) + thrombin; and antithrombin + thrombin. All serpin sequences correspond to human molecules. The models show correct stereochemistry and no steric clashes between protease and inhibitor. The main structural differences in the serpins from the parent structures are: (1) the reactive center loop is inserted into the A-sheet as far as P12; (2) strand s1C is removed from the C-sheet; and (3) the C-terminus has changed conformation and interacts with the protease. In the absence of an X-ray structure determination of a serpin-protease complex, the demonstration that insertion of the reactive center loop into the A-sheet as far as P12 is stereochemically feasible provides structures of a protease-bound conformation of intact serpins with which to rationalize the properties of mutants, guide the design of experiments, and form a basis for fur...Continue Reading

References

Apr 1, 1977·Computers in Biology and Medicine·A M Lesk
May 25, 1977·Journal of Molecular Biology·F C BernsteinM Tasumi
Feb 20, 1992·Journal of Molecular Biology·A S Kolaskar, U Kulkarni-Kale
Jan 16, 1992·Nature·J MottonenE J Goldsmith
Sep 20, 1991·Journal of Molecular Biology·P Stein, C Chothia
Nov 26, 1990·European Journal of Biochemistry·A J SchulzeC B Laurell
Jan 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·M A NaviaK Hoogsteen
Jan 1, 1989·The Biochemical Journal·A WallaceS R Stone
Feb 14, 1971·Journal of Molecular Biology·B Lee, F M Richards
Apr 20, 1967·Biochemical and Biophysical Research Communications·I Schechter, A Berger
Jan 1, 1983·Annual Review of Biochemistry·J Travis, G S Salvesen
Jul 1, 1995·Proteins·H T Wright, J N Scarsdale
Oct 27, 1995·The Journal of Biological Chemistry·D A LawrenceJ D Shore
Feb 1, 1995·Nature Structural Biology·P E Stein, R W Carrell
Feb 1, 1994·Protein Science : a Publication of the Protein Society·Z S Hendsch, B Tidor
Apr 15, 1994·Structure·R W CarrellM R Wardell
Sep 1, 1993·Protein Engineering·D S Katz, D W Christianson
Jul 5, 1993·Journal of Molecular Biology·L MoureyD Moras
Aug 3, 1993·Biochemistry·P C HopkinsS R Stone

❮ Previous
Next ❯

Citations

May 19, 2009·Immunity·Katherine BaranJoseph A Trapani
Apr 15, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Philippa J TalmudUNKNOWN Diabetes Atherosclerosis Intervention Study Investigators
Jun 15, 2011·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Gwenhael JégotBrice Korkmaz
Oct 12, 2000·The Journal of Biological Chemistry·K M O'Malley, B S Cooperman
Jun 23, 1998·The Journal of Biological Chemistry·E Stratikos, P G Gettins
Oct 5, 2001·The Journal of Biological Chemistry·J C FredenburghJ I Weitz
Feb 28, 1998·The Journal of Biological Chemistry·K N LeeM H Yu
Feb 7, 2001·The Journal of Biological Chemistry·P Mellet, J G Bieth
Oct 28, 2016·Journal of Thrombosis and Haemostasis : JTH·A HenneuseM C Alessi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.